FDA
- Status: approved
🇺🇸 lenvatinib plus anti-PD-1 antibody in United States
lenvatinib plus anti-PD-1 antibody (lenvatinib plus anti-PD-1 antibody) regulatory status in United States.
Marketing authorisation
lenvatinib plus anti-PD-1 antibody in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is lenvatinib plus anti-PD-1 antibody approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for lenvatinib plus anti-PD-1 antibody in United States?
Fudan University is the originator. The local marketing authorisation holder may differ — check the official source linked above.